Rubicon Research's Team
We have a team of highly dedicated, experienced and knowledgeable formulation and analytical chemists with a proven track record in developing pulmonary and nasal drug products.
Rubicon Research Canada Ltd is a Toronto, Canada-based developer of pharmaceutical products and complex formulations focused on inhalation pharmaceutical products (solution and suspension nasal sprays and pMDIs).
The company was formerly called Impopharma Canada Ltd, and was acquired by Rubicon Research Pvt Ltd in 2020. It was founded in 1996 as a CRO by Hanna Piskorz and Harold Wulffhart in a single office enterprise of ~150 ft². It has grown over a span of 20 years with a footprint of ~15,000 ft² comprised of laboratory, potential small pilot manufacturing, document storage, sample storage and office space operating within an FDA and Health inspected QMS.
Over the years, the company has acted as an extension of the client’s laboratory, including top 20 global Rx pharma companies, and has equipped itself with highly specialized equipment, key scientists as well as expertise in many product development strategies in line with current regulatory expectations.